GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rewalk Robotics Ltd (NAS:LFWD) » Definitions » Altman Z-Score

Rewalk Robotics (Rewalk Robotics) Altman Z-Score : -4.20 (As of Apr. 30, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Rewalk Robotics Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of -4.19 is in distress zone. This implies bankruptcy possibility in the next two years.

Rewalk Robotics has a Altman Z-Score of -4.20, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Rewalk Robotics's Altman Z-Score or its related term are showing as below:

LFWD' s Altman Z-Score Range Over the Past 10 Years
Min: -16.93   Med: -4.92   Max: 33.85
Current: -4.19

During the past 12 years, Rewalk Robotics's highest Altman Z-Score was 33.85. The lowest was -16.93. And the median was -4.92.


Rewalk Robotics Altman Z-Score Historical Data

The historical data trend for Rewalk Robotics's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rewalk Robotics Altman Z-Score Chart

Rewalk Robotics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.14 -6.24 6.47 0.80 -3.96

Rewalk Robotics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.55 -1.43 -3.43 -3.96

Competitive Comparison of Rewalk Robotics's Altman Z-Score

For the Medical Devices subindustry, Rewalk Robotics's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rewalk Robotics's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rewalk Robotics's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Rewalk Robotics's Altman Z-Score falls into.



Rewalk Robotics Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Rewalk Robotics's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.434+1.4*-3.7328+3.3*-0.3501+0.6*2.4016+1.0*0.2192
=-4.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was $63.19 Mil.
Total Current Assets was $39.22 Mil.
Total Current Liabilities was $11.80 Mil.
Retained Earnings was $-235.88 Mil.
Pre-Tax Income was -5.717 + -7.531 + -4.6 + -4.297 = $-22.15 Mil.
Interest Expense was -0.004 + 0 + -0.008 + -0.008 = $-0.02 Mil.
Revenue was 6.884 + 4.403 + 1.337 + 1.23 = $13.85 Mil.
Market Cap (Today) was $40.06 Mil.
Total Liabilities was $16.68 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(39.222 - 11.795)/63.192
=0.434

X2=Retained Earnings/Total Assets
=-235.883/63.192
=-3.7328

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-22.145 - -0.02)/63.192
=-0.3501

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=40.063/16.682
=2.4016

X5=Revenue/Total Assets
=13.854/63.192
=0.2192

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Rewalk Robotics has a Altman Z-Score of -4.20 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Rewalk Robotics  (NAS:LFWD) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Rewalk Robotics Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Rewalk Robotics's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Rewalk Robotics (Rewalk Robotics) Business Description

Traded in Other Exchanges
Address
3 Hatnufa Street, P.O. Box 161, Floor 6, Yokneam Ilit, ISR, 2069203
ReWalk Robotics Ltd is an Israel based medical device company. It is engaged in designing, developing and commercializing the Rewalk systems which are exoskeletons allowing wheelchair-bound individuals to stand and walk once again. It offers two systems, ReWalk Personal which is designed for every day and all day use by individuals at home and in their communities and is custom-fit for each user; and ReWalk Rehabilitation which is designed for the clinical rehabilitation environment where it provides the user with valuable training exercise and therapy. The company generates maximum revenue from the United States and Europe.
Executives
Lind Global Fund Ii Lp 10 percent owner 444 MADISON AVENUE, 41ST FLOOR, NEW YORK NY 10022
Lind Global Macro Fund Lp 10 percent owner 444 MADISON AVE, FLOOR 41, NEW YORK NY 10022
Turk Joseph E Jr director NXSTAGE MEDICAL INC, 439 SOUTH UNION STREET 5TH FLOOR, LAWRENCE MA 01843
Jeannine Lynch officer: VP of Market Access & Strategy C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., P.O. BOX 161, YOKNEAM ILIT L3 20692203
Michael A Lawless officer: Chief Financial Officer C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Jeff Dykan director KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Aryeh Dan director KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Charles Remsberg officer: Chief Sales Officer C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Lawrence J Jasinski director, officer: Chief Executive Officer SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
Randel Richner director C/O REWALK ROBOTICS, LTD., 3 HATNUFA ST. 6TH FL. P.O. BOX 161, YOKNEAM L3 2069203
Hadar Levy director C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Poduska John William Sr director 295 MEADOWBROOK RD, WESTON MA 02493
Yasushi Ichiki director KOCHAV YOKNEAM BUILDING, FLOOR 6, P.O. BOX 161, YOKNEAM ILIT L3 20692
Yohanan Engelhardt director 3 HATNUFA ST., FLOOR 6, YOKNEAM ILIT L3 2069203
Wayne Weisman director 490 LAPP ROAD, MALVERN PA 19355